Why are we still calling Menopause a gynaecological problem?
If PCOS can be reclassified as Polyendocrine Metabolic Ovarian Syndrome (PMOS), isn't it time we reconsidered Menopause too?
For decades, menopause has been largely categorised as a gynaecological issue. It is a reproductive milestone, a hormonal event, the end of menstruation. Case closed.
Yet the more science uncovers about menopause, the less that description seems to fit. What if menopause has been sitting in the wrong medical department all along? Because if we step back and examine what actually happens during menopause, it becomes increasingly difficult to argue that it is simply a reproductive transition.
What we see instead is a profound biological shift that affects virtually every major system in the female body. Which raises an important question: Why are we still calling menopause a gynaecological problem?
A Precedent Already Exists
This would not be the first time medicine has had to rethink a diagnosis. Historically, Polycystic Ovary Syndrome (PCOS) was viewed primarily as an ovarian condition. The name itself suggested the ovaries were the centre of the problem. Yet over time, research revealed a much broader picture: Insulin resistance, Metabolic dysfunction, Inflammation, Adrenal involvement, Cardiovascular implications, multiple hormonal pathways interacting simultaneously.
As understanding evolved, many researchers and clinicians began advocating for the term:
Polyendocrine Metabolic Ovarian Syndrome (PMOS).
The significance of PMOS is not merely semantic. The name acknowledges that the condition extends beyond the ovaries. It recognises the involvement of multiple endocrine systems and the wider metabolic consequences affecting the whole body. In other words, the language evolved because the science evolved.
So perhaps we should ask: If PCOS required a reclassification to reflect its systemic nature, why has menopause not undergone the same scrutiny?
The Menopause We Describe Versus the Menopause Women Experience
The current medical definition of menopause is remarkably narrow. It refers to the point at which a woman has gone twelve consecutive months without a menstrual period. One day. One marker. One reproductive milestone. Yet ask women about their actual experience and a very different picture emerges. They describe changes in:
Brain function and memory
Sleep quality
Mood and anxiety
Cardiovascular health
Metabolism
Muscle mass
Bone density
Joint health
Energy production
Sexual function
Bladder health
Immune regulation
Cognitive performance
The list continues to expand. Many women first seek help not because of hot flushes but because of:
Brain fog
Weight gain
Fatigue
Insomnia
Palpitations
Recurrent urinary tract infections
Joint pain
Anxiety
Loss of confidence
Reduced exercise tolerance
These are not exclusively reproductive symptoms. They are whole-body symptoms.
Menopause as a Systemic Health Transition
The decline in ovarian hormones influences multiple physiological systems. Oestrogen receptors are found throughout the body, including:
The brain
Blood vessels
Bones
Muscles
Skin
Bladder
Pelvic floor
Heart
Immune tissues
When ovarian hormone production changes, these systems respond.
This is why menopause increasingly appears to be less a gynaecological event and more a systemic health transition: cardiovascular risk begins to rise; bone density declines; muscle mass decreases; insulin sensitivity changes; the risk profile for dementia shifts; the incidence of urinary tract infections increases; sleep architecture changes. These are not secondary consequences. They are central features of the transition itself.
The Cost of a Narrow Definition
Language matters. Classification matters. Because classification influences healthcare pathways. If menopause is viewed primarily as a reproductive issue, women are often directed toward symptom management. If menopause were viewed as a broader metabolic, neurological, cardiovascular and musculoskeletal transition, healthcare systems might approach it very differently.
Imagine if every woman entering menopause routinely received support around:
Cardiovascular health
Strength training
Bone density preservation
Cognitive health
Metabolic resilience
Sleep optimisation
Nutrition
Pelvic floor function
Mental health
Instead of asking only: are you having hot flushes?. We might ask: how are we preparing to support you for the next forty years?
Perhaps Menopause Needs a New Name
The word menopause literally describes the ending of menstrual cycles. But perhaps that definition is now too small for what we know. Perhaps the challenge is not menopause itself. Perhaps the challenge is that our language has failed to evolve alongside the science. If PMOS acknowledges the systemic nature of what was once viewed as an ovarian condition, what terminology might better describe menopause? Some possibilities might include:
Female Endocrine Transition Syndrome (FETS) - acknowledging widespread endocrine changes beyond reproduction.
Midlife Neuroendocrine Transition (MNT) - recognising the profound interaction between hormones, metabolism and brain health.
The Longevity Transition - perhaps a more hopeful framing of all, because menopause is not the end of life. For many women it marks the beginning of another thirty, forty or even fifty years. It is not a conclusion. It is a gateway.
A Different Lens
Perhaps the greatest misconception surrounding menopause is that it represents decline. What if it actually represents adaptation? What if it is one of the most important health transitions a woman will ever experience? Not because something is wrong. But because everything is changing. And when everything is changing, our understanding must change too. Medicine evolves, language evolves and the science evolves.
Perhaps it is time menopause evolved as well. Not to erase the word. But to expand the conversation. Because if menopause affects the brain, heart, bones, muscles, metabolism, bladder, immune system and future health trajectory... Then surely the question is no longer whether it is a gynaecological issue. The question is: Why are we still treating it as if it is only one?
Author's Reflection
Of all the possible alternative name, my personal favourite is:
Female Neuroendocrine Transition (FNT)
Why? Because unlike menopause, it immediately conveys two things that women know instinctively from lived experience. First, that this is not simply a reproductive event. The term neuroendocrine acknowledges the intricate conversation occurring between the brain, nervous system, hormones, metabolism, sleep, mood, cognition, cardiovascular health, musculoskeletal health, bladder function and future ageing trajectories. It reflects the reality that menopause is not confined to the ovaries. It is a whole-body phenomenon.
Second, it acknowledges that this is a transition, not an event. The word menopause centres around a single moment in time: twelve months without a period. Yet most women experience this journey over years, sometimes decades. Their symptoms do not arrive on one particular day and neither do the opportunities for intervention, education, prevention and support.
A transition suggests movement, adaptation, evolution, a journey from one physiological state to another. Perhaps most importantly, it removes some of the language of ending. The word menopause has always felt like a full stop, a conclusion, a shutting down.
Female Neuroendocrine Transition feels more like a comma, an acknowledgement that something significant is changing, while recognising that life, health, purpose, possibility and hope continue. Because for most women, this isn't the end of anything. It's the beginning of the next chapter.
